| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |